We only demonstrated it at the cellular level, lacking actual clinical studies to support it, and we failed to explore the potential regulatory mechanisms by which NSUN4 targets and affects the mTOR pathway, as well as the potential molecular mechanisms by which mTOR affects HCC, which is our ongoing subject. Here, NSUN4 is linked to hepatocellular carcinoma.